| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC12A6 SPNS1 ABCA1 CNNM2 SLC13A3 SLC35F1 CHRNB3 SLC12A5 GJA8 SLC39A12 CACNA2D4 CLCN1 KCNU1 CATSPER2 KCNJ9 SLC22A3 SLC22A2 ABCD4 SLC38A7 SLC45A2 GJA10 GJC3 ABCC2 SCN3B | 2.20e-09 | 1180 | 99 | 24 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC12A6 SPNS1 ABCA1 CNNM2 SLC13A3 SLC35F1 CHRNB3 SLC12A5 GJA8 SLC39A12 CACNA2D4 CLCN1 KCNU1 CATSPER2 KCNJ9 SLC22A3 SLC22A2 ABCD4 SLC38A7 SLC45A2 GJA10 GJC3 ABCC2 SCN3B | 1.24e-08 | 1289 | 99 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | IL12RB1 IL13RA2 ABCA1 TPRA1 NPY6R OR2T27 NPSR1 TAAR3P TSHR ADGRE2 OR6P1 BDKRB2 CHRNB3 CCKBR ADORA3 TAS2R8 P2RY4 GPR157 GLP1R SCTR ROS1 LTB4R IL27RA | 1.40e-07 | 1353 | 99 | 23 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 3.23e-07 | 133 | 99 | 8 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 4.78e-07 | 140 | 99 | 8 | GO:0001653 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | TPRA1 NPY6R OR2T27 NPSR1 TAAR3P TSHR ADGRE2 OR6P1 BDKRB2 CCKBR ADORA3 TAS2R8 P2RY4 GPR157 GLP1R SCTR LTB4R | 1.50e-06 | 884 | 99 | 17 | GO:0004930 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.12e-06 | 119 | 99 | 7 | GO:0015294 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC12A6 CNNM2 SLC13A3 SLC12A5 SLC39A12 CACNA2D4 KCNU1 CATSPER2 KCNJ9 SLC22A3 SLC38A7 SCN3B | 3.26e-06 | 465 | 99 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC12A6 CNNM2 SLC13A3 SLC12A5 SLC39A12 CACNA2D4 CLCN1 KCNU1 CATSPER2 KCNJ9 SLC22A3 SLC38A7 SLC45A2 ABCC2 SCN3B | 4.73e-06 | 758 | 99 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | antigen binding | DHCR24 IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-28 IGHV4-4 | 4.74e-06 | 190 | 99 | 8 | GO:0003823 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC12A6 CNNM2 SLC13A3 CHRNB3 SLC12A5 SLC39A12 CACNA2D4 KCNU1 CATSPER2 KCNJ9 SLC22A3 SLC38A7 SLC45A2 SCN3B | 4.93e-06 | 664 | 99 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC12A6 CNNM2 SLC13A3 CHRNB3 SLC12A5 SLC39A12 CACNA2D4 CLCN1 KCNU1 CATSPER2 KCNJ9 SLC22A3 SLC38A7 SLC45A2 SCN3B | 8.13e-06 | 793 | 99 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | symporter activity | 9.80e-06 | 150 | 99 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | channel activity | SLC12A6 CHRNB3 SLC12A5 GJA8 CACNA2D4 CLCN1 KCNU1 CATSPER2 KCNJ9 GJA10 GJC3 SCN3B | 1.11e-05 | 525 | 99 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC12A6 CHRNB3 SLC12A5 GJA8 CACNA2D4 CLCN1 KCNU1 CATSPER2 KCNJ9 GJA10 GJC3 SCN3B | 1.14e-05 | 526 | 99 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC12A6 CNNM2 SLC13A3 SLC12A5 SLC39A12 CACNA2D4 KCNU1 CATSPER2 KCNJ9 SLC22A3 SLC38A7 SLC45A2 SCN3B | 1.32e-05 | 627 | 99 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC12A6 ABCA1 SLC13A3 SLC12A5 SLC39A12 SLC22A3 SLC22A2 ABCD4 SLC38A7 SLC45A2 ABCC2 | 2.45e-05 | 477 | 99 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.95e-04 | 23 | 99 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | spermidine transmembrane transporter activity | 2.41e-04 | 5 | 99 | 2 | GO:0015606 | |
| GeneOntologyMolecularFunction | gap junction channel activity | 2.51e-04 | 25 | 99 | 3 | GO:0005243 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 2.83e-04 | 26 | 99 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | hydroperoxy icosatetraenoate dehydratase activity | 5.03e-04 | 7 | 99 | 2 | GO:0106256 | |
| GeneOntologyMolecularFunction | sphingosine N-acyltransferase activity | 5.03e-04 | 7 | 99 | 2 | GO:0050291 | |
| GeneOntologyMolecularFunction | acylglycerol O-acyltransferase activity | 5.28e-04 | 32 | 99 | 3 | GO:0016411 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 6.42e-04 | 293 | 99 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | diacylglycerol O-acyltransferase activity | 6.68e-04 | 8 | 99 | 2 | GO:0004144 | |
| GeneOntologyMolecularFunction | 2-acylglycerol O-acyltransferase activity | 6.68e-04 | 8 | 99 | 2 | GO:0003846 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 6.82e-04 | 296 | 99 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 7.52e-04 | 301 | 99 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | wide pore channel activity | 8.13e-04 | 37 | 99 | 3 | GO:0022829 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 8.56e-04 | 9 | 99 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 1.30e-03 | 11 | 99 | 2 | GO:0015203 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 1.30e-03 | 11 | 99 | 2 | GO:0101020 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 1.55e-03 | 12 | 99 | 2 | GO:0008504 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 1.55e-03 | 12 | 99 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 1.55e-03 | 12 | 99 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.62e-03 | 171 | 99 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.85e-03 | 49 | 99 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | quaternary ammonium group transmembrane transporter activity | 2.45e-03 | 15 | 99 | 2 | GO:0015651 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 2.57e-03 | 55 | 99 | 3 | GO:0017046 | |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 3.14e-03 | 59 | 99 | 3 | GO:0008374 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.45e-03 | 61 | 99 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 3.48e-03 | 125 | 99 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 3.71e-03 | 207 | 99 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | hydro-lyase activity | 3.78e-03 | 63 | 99 | 3 | GO:0016836 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 3.79e-03 | 208 | 99 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 4.81e-03 | 21 | 99 | 2 | GO:0005326 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 5.21e-03 | 140 | 99 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 5.27e-03 | 22 | 99 | 2 | GO:0016500 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 5.29e-03 | 71 | 99 | 3 | GO:0015179 | |
| GeneOntologyMolecularFunction | gated channel activity | 6.39e-03 | 334 | 99 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 6.66e-03 | 238 | 99 | 5 | GO:0016747 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 6.79e-03 | 151 | 99 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 7.24e-03 | 343 | 99 | 6 | GO:0005261 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | IL13RA2 IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-28 IGHV4-4 IL27RA | 1.97e-06 | 235 | 99 | 9 | GO:0016064 |
| GeneOntologyBiologicalProcess | B cell mediated immunity | IL13RA2 IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-28 IGHV4-4 IL27RA | 2.69e-06 | 244 | 99 | 9 | GO:0019724 |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | IL12RB1 IL13RA2 ADGRE2 ADORA3 ADAM17 IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-28 IGHV4-4 IL27RA | 3.77e-06 | 576 | 99 | 13 | GO:0002443 |
| GeneOntologyBiologicalProcess | histamine transport | 5.85e-06 | 25 | 99 | 4 | GO:0051608 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | IL12RB1 IL13RA2 ADAM17 IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-28 IGHV4-4 IL27RA | 1.35e-05 | 462 | 99 | 11 | GO:0002460 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC12A6 CNNM2 NPSR1 SLC13A3 CHRNB3 SLC12A5 SLC39A12 CACNA2D4 CLCN1 KCNU1 CATSPER2 P2RY4 GLP1R KCNJ9 SLC22A3 SLC22A2 SLC38A7 ABCC2 SCN3B | 2.51e-05 | 1374 | 99 | 19 | GO:0006811 |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | IL12RB1 IL13RA2 IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-28 IGHV4-4 IL27RA | 5.98e-05 | 449 | 99 | 10 | GO:0002449 |
| GeneOntologyBiologicalProcess | immune effector process | IL12RB1 IL13RA2 CD244 ADGRE2 ADORA3 ADAM17 IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-28 IGHV4-4 IL27RA | 6.01e-05 | 859 | 99 | 14 | GO:0002252 |
| GeneOntologyBiologicalProcess | response to 3-methylcholanthrene | 6.82e-05 | 3 | 99 | 2 | GO:1904681 | |
| GeneOntologyBiologicalProcess | response to polycyclic arene | 6.82e-05 | 3 | 99 | 2 | GO:1903165 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | ABCA1 TPRA1 NPY6R OR2T27 NPSR1 TAAR3P TSHR ADGRE2 OR6P1 BDKRB2 CCKBR ADORA3 TAS2R8 P2RY4 GPR157 GLP1R SCTR LTB4R | 1.04e-04 | 1395 | 99 | 18 | GO:0007186 |
| GeneOntologyBiologicalProcess | histamine uptake | 1.36e-04 | 4 | 99 | 2 | GO:0051615 | |
| GeneOntologyBiologicalProcess | spermidine transmembrane transport | 1.36e-04 | 4 | 99 | 2 | GO:1903711 | |
| GeneOntologyBiologicalProcess | cellular response to high density lipoprotein particle stimulus | 1.36e-04 | 4 | 99 | 2 | GO:0071403 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC13A3 BDKRB2 LLGL2 SLC22A3 SLC22A2 ABCD4 SLC38A7 ABCC2 ACSL5 | 1.59e-04 | 410 | 99 | 9 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC13A3 BDKRB2 LLGL2 SLC22A3 SLC22A2 ABCD4 SLC38A7 ABCC2 ACSL5 | 1.65e-04 | 412 | 99 | 9 | GO:0015849 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC13A3 BDKRB2 SLC39A12 LLGL2 SLC22A3 SLC22A2 ABCD4 SLC38A7 ABCC2 ACSL5 | 1.84e-04 | 515 | 99 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | dibenzo-p-dioxin metabolic process | 2.26e-04 | 5 | 99 | 2 | GO:0018894 | |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 2.28e-04 | 25 | 99 | 3 | GO:0055064 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC12A6 CNNM2 NPSR1 SLC13A3 CHRNB3 SLC12A5 SLC39A12 CACNA2D4 CLCN1 KCNU1 CATSPER2 GLP1R KCNJ9 ABCC2 SCN3B | 2.69e-04 | 1115 | 99 | 15 | GO:0034220 |
| GeneOntologyBiologicalProcess | metal ion transport | SLC12A6 CNNM2 NPSR1 SLC13A3 SLC12A5 SLC39A12 CACNA2D4 KCNU1 CATSPER2 GLP1R KCNJ9 SLC38A7 ABCC2 SCN3B | 2.94e-04 | 1000 | 99 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | secondary metabolic process | 3.04e-04 | 67 | 99 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 3.20e-04 | 191 | 99 | 6 | GO:0007189 | |
| GeneOntologyBiologicalProcess | monoatomic anion homeostasis | 3.22e-04 | 28 | 99 | 3 | GO:0055081 | |
| GeneOntologyBiologicalProcess | xenobiotic transport across blood-brain barrier | 3.38e-04 | 6 | 99 | 2 | GO:1990962 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 3.38e-04 | 6 | 99 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | spermidine transport | 3.38e-04 | 6 | 99 | 2 | GO:0015848 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC12A6 CNNM2 NPSR1 SLC13A3 SLC12A5 SLC39A12 CACNA2D4 CLCN1 KCNU1 CATSPER2 GLP1R KCNJ9 ABCC2 SCN3B | 3.49e-04 | 1017 | 99 | 14 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC12A6 CNNM2 NPSR1 SLC13A3 SLC12A5 SLC39A12 CACNA2D4 KCNU1 CATSPER2 GLP1R KCNJ9 SLC22A2 SLC38A7 ABCC2 SCN3B | 3.99e-04 | 1157 | 99 | 15 | GO:0006812 |
| GeneOntologyBiologicalProcess | fatty acid transport | 4.40e-04 | 132 | 99 | 5 | GO:0015908 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC12A6 CNNM2 NPSR1 SLC13A3 SLC12A5 SLC39A12 CACNA2D4 KCNU1 CATSPER2 GLP1R KCNJ9 ABCC2 SCN3B | 4.60e-04 | 922 | 99 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC12A6 CNNM2 NPSR1 SLC13A3 SLC12A5 SLC39A12 CACNA2D4 KCNU1 CATSPER2 GLP1R KCNJ9 ABCC2 SCN3B | 5.63e-04 | 942 | 99 | 13 | GO:0098655 |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 5.70e-04 | 213 | 99 | 6 | GO:0015718 | |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 5.76e-04 | 34 | 99 | 3 | GO:0007190 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | SLC12A6 SPNS1 CNNM2 NPSR1 CCKBR SLC12A5 SLC39A12 P2RY4 GLP1R SLC45A2 ABCC2 | 6.50e-04 | 717 | 99 | 11 | GO:0050801 |
| GeneOntologyBiologicalProcess | adaptive immune response | IL12RB1 IL13RA2 CD244 ADAM17 IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-28 IGHV4-4 IL27RA | 6.74e-04 | 838 | 99 | 12 | GO:0002250 |
| GeneOntologyBiologicalProcess | secretion | IL13RA2 ABCA1 NPSR1 ADGRE2 BDKRB2 CCKBR ADORA3 MYOF LLGL2 MCTP1 P2RY4 GLP1R SLC22A2 ADAM17 ABCC2 | 6.99e-04 | 1221 | 99 | 15 | GO:0046903 |
| GeneOntologyBiologicalProcess | lipid transport | SPNS1 ABCA1 SLC66A2 SLC13A3 BDKRB2 SLC22A2 ABCD4 ABCC2 ACSL5 | 7.35e-04 | 506 | 99 | 9 | GO:0006869 |
| GeneOntologyBiologicalProcess | norepinephrine transport | 8.01e-04 | 38 | 99 | 3 | GO:0015874 | |
| GeneOntologyBiologicalProcess | norepinephrine uptake | 8.03e-04 | 9 | 99 | 2 | GO:0051620 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 8.19e-04 | 87 | 99 | 4 | GO:0150104 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 8.32e-04 | 412 | 99 | 8 | GO:0006066 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 8.51e-04 | 230 | 99 | 6 | GO:0098739 | |
| GeneOntologyBiologicalProcess | vascular transport | 8.55e-04 | 88 | 99 | 4 | GO:0010232 | |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 9.32e-04 | 40 | 99 | 3 | GO:0045762 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | CYP1A1 CYP1B1 ABCA1 CD244 MYOF DUOXA1 PLPP2 DHCR24 SLC45A2 MOGAT3 | 1.02e-03 | 641 | 99 | 10 | GO:1901615 |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 1.07e-03 | 42 | 99 | 3 | GO:0006884 | |
| GeneOntologyBiologicalProcess | regulation of mast cell degranulation | 1.07e-03 | 42 | 99 | 3 | GO:0043304 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | CERS2 CYP1A1 CYP1B1 ABCA1 CISD2 AGPAT4 CERS6 EXTL3 TMEM129 MCTP1 DUOXA1 PLPP2 BCAP29 SERINC1 TRAM1 SLC22A3 DHCR24 ABCD4 EMD TMEM68 MOGAT3 ACSL5 | 2.35e-07 | 1327 | 100 | 22 | GO:0042175 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | CERS2 CYP1A1 CYP1B1 ABCA1 CISD2 AGPAT4 CERS6 EXTL3 TMEM129 MCTP1 DUOXA1 PLPP2 BCAP29 SERINC1 TRAM1 DHCR24 ABCD4 EMD TMEM68 MOGAT3 ACSL5 | 7.05e-07 | 1299 | 100 | 21 | GO:0098827 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | CERS2 CYP1A1 CYP1B1 ABCA1 CISD2 AGPAT4 CERS6 EXTL3 TMEM129 MCTP1 DUOXA1 PLPP2 BCAP29 SERINC1 TRAM1 DHCR24 ABCD4 TMEM68 MOGAT3 ACSL5 | 2.68e-06 | 1293 | 100 | 20 | GO:0005789 |
| GeneOntologyCellularComponent | immunoglobulin complex | IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-28 IGHV4-4 | 1.51e-05 | 166 | 100 | 7 | GO:0019814 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.52e-04 | 320 | 100 | 8 | GO:0016323 | |
| GeneOntologyCellularComponent | connexin complex | 1.53e-04 | 22 | 100 | 3 | GO:0005922 | |
| GeneOntologyCellularComponent | basal plasma membrane | 3.00e-04 | 354 | 100 | 8 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 4.65e-04 | 378 | 100 | 8 | GO:0045178 | |
| GeneOntologyCellularComponent | gap junction | 7.33e-04 | 37 | 100 | 3 | GO:0005921 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | COX6A2 CHRNB3 CACNA2D4 CLCN1 KCNU1 CATSPER2 KCNJ9 ABCD4 SCN3B | 9.08e-04 | 523 | 100 | 9 | GO:1902495 |
| GeneOntologyCellularComponent | bBAF complex | 9.94e-04 | 10 | 100 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | transporter complex | COX6A2 CHRNB3 CACNA2D4 CLCN1 KCNU1 CATSPER2 KCNJ9 ABCD4 SCN3B | 1.29e-03 | 550 | 100 | 9 | GO:1990351 |
| GeneOntologyCellularComponent | npBAF complex | 1.99e-03 | 14 | 100 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 1.99e-03 | 14 | 100 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.27e-03 | 378 | 100 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | nBAF complex | 2.60e-03 | 16 | 100 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | spindle pole centrosome | 3.67e-03 | 19 | 100 | 2 | GO:0031616 | |
| Domain | SnAC | 2.30e-05 | 2 | 90 | 2 | SM01314 | |
| Domain | Gln-Leu-Gln_QLQ | 2.30e-05 | 2 | 90 | 2 | IPR014978 | |
| Domain | SnAC | 2.30e-05 | 2 | 90 | 2 | IPR029295 | |
| Domain | SnAC | 2.30e-05 | 2 | 90 | 2 | PF14619 | |
| Domain | QLQ | 2.30e-05 | 2 | 90 | 2 | SM00951 | |
| Domain | QLQ | 2.30e-05 | 2 | 90 | 2 | PS51666 | |
| Domain | QLQ | 2.30e-05 | 2 | 90 | 2 | PF08880 | |
| Domain | TLC | 5.79e-05 | 16 | 90 | 3 | PS50922 | |
| Domain | TLC | 5.79e-05 | 16 | 90 | 3 | SM00724 | |
| Domain | TRAM_LAG1_CLN8 | 5.79e-05 | 16 | 90 | 3 | PF03798 | |
| Domain | TLC-dom | 5.79e-05 | 16 | 90 | 3 | IPR006634 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 9.80e-05 | 50 | 90 | 4 | PS00650 | |
| Domain | 7tm_2 | 9.80e-05 | 50 | 90 | 4 | PF00002 | |
| Domain | CONNEXINS_1 | 9.92e-05 | 19 | 90 | 3 | PS00407 | |
| Domain | CONNEXINS_2 | 1.16e-04 | 20 | 90 | 3 | PS00408 | |
| Domain | Connexin | 1.16e-04 | 20 | 90 | 3 | IPR000500 | |
| Domain | Connexin_CCC | 1.16e-04 | 20 | 90 | 3 | IPR019570 | |
| Domain | Connexin_N | 1.16e-04 | 20 | 90 | 3 | IPR013092 | |
| Domain | Connexin | 1.16e-04 | 20 | 90 | 3 | PF00029 | |
| Domain | Connexin_CCC | 1.16e-04 | 20 | 90 | 3 | SM01089 | |
| Domain | Connexin_CS | 1.16e-04 | 20 | 90 | 3 | IPR017990 | |
| Domain | CNX | 1.16e-04 | 20 | 90 | 3 | SM00037 | |
| Domain | HSA | 1.37e-04 | 4 | 90 | 2 | SM00573 | |
| Domain | HSA | 1.37e-04 | 4 | 90 | 2 | PS51204 | |
| Domain | HSA_dom | 1.37e-04 | 4 | 90 | 2 | IPR014012 | |
| Domain | HSA | 1.37e-04 | 4 | 90 | 2 | PF07529 | |
| Domain | KCL_cotranspt | 1.37e-04 | 4 | 90 | 2 | IPR000076 | |
| Domain | GPCR_2_secretin-like | 2.00e-04 | 60 | 90 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 2.00e-04 | 60 | 90 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 2.13e-04 | 61 | 90 | 4 | PS50261 | |
| Domain | BRK | 3.40e-04 | 6 | 90 | 2 | SM00592 | |
| Domain | BRK_domain | 3.40e-04 | 6 | 90 | 2 | IPR006576 | |
| Domain | Lag1/Lac1 | 3.40e-04 | 6 | 90 | 2 | IPR016439 | |
| Domain | BRK | 3.40e-04 | 6 | 90 | 2 | PF07533 | |
| Domain | GPCR_Rhodpsn_7TM | OR2T27 NPSR1 TSHR OR6P1 BDKRB2 CCKBR ADORA3 TAS2R8 P2RY4 GPR157 LTB4R | 3.70e-04 | 670 | 90 | 11 | IPR017452 |
| Domain | SLC12A_fam | 4.75e-04 | 7 | 90 | 2 | IPR004842 | |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2T27 NPSR1 TAAR3P TSHR OR6P1 BDKRB2 CCKBR ADORA3 TAS2R8 P2RY4 LTB4R | 4.79e-04 | 691 | 90 | 11 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2T27 NPSR1 TAAR3P TSHR OR6P1 BDKRB2 CCKBR ADORA3 TAS2R8 P2RY4 LTB4R | 4.85e-04 | 692 | 90 | 11 | IPR000276 |
| Domain | GPCR_2_secretin-like_CS | 5.81e-04 | 34 | 90 | 3 | IPR017983 | |
| Domain | SLC12_C | 6.31e-04 | 8 | 90 | 2 | IPR018491 | |
| Domain | SLC12 | 6.31e-04 | 8 | 90 | 2 | PF03522 | |
| Domain | HEMATOPO_REC_L_F2 | 6.31e-04 | 8 | 90 | 2 | PS01353 | |
| Domain | Orgcat_transp/SVOP | 8.09e-04 | 9 | 90 | 2 | IPR004749 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 9.40e-04 | 40 | 90 | 3 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 9.40e-04 | 40 | 90 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 9.40e-04 | 40 | 90 | 3 | PS50227 | |
| Domain | ABC_transporter_CS | 1.08e-03 | 42 | 90 | 3 | IPR017871 | |
| Domain | 7tm_1 | OR2T27 NPSR1 TAAR3P TSHR OR6P1 BDKRB2 CCKBR ADORA3 P2RY4 LTB4R | 1.54e-03 | 677 | 90 | 10 | PF00001 |
| Domain | ABC_tran | 1.60e-03 | 48 | 90 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.60e-03 | 48 | 90 | 3 | PS50893 | |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2T27 NPSR1 TAAR3P TSHR OR6P1 BDKRB2 CCKBR ADORA3 P2RY4 LTB4R | 1.68e-03 | 685 | 90 | 10 | PS00237 |
| Domain | ABC_TRANSPORTER_1 | 1.70e-03 | 49 | 90 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 1.80e-03 | 50 | 90 | 3 | IPR003439 | |
| Domain | Acyltransferase | 2.64e-03 | 16 | 90 | 2 | PF01553 | |
| Domain | PlsC | 2.98e-03 | 17 | 90 | 2 | SM00563 | |
| Domain | SUGAR_TRANSPORT_2 | 2.98e-03 | 17 | 90 | 2 | PS00217 | |
| Domain | Plipid/glycerol_acylTrfase | 2.98e-03 | 17 | 90 | 2 | IPR002123 | |
| Domain | MFS_dom | 4.02e-03 | 134 | 90 | 4 | IPR020846 | |
| Domain | CBS_dom | 4.12e-03 | 20 | 90 | 2 | IPR000644 | |
| Domain | CBS | 4.12e-03 | 20 | 90 | 2 | PF00571 | |
| Domain | CBS | 4.12e-03 | 20 | 90 | 2 | PS51371 | |
| Pathway | WP_GPCRS_NONODORANT | NPY6R NPSR1 TSHR ADGRE2 BDKRB2 CCKBR ADORA3 P2RY4 GLP1R SCTR LTB4R | 2.55e-07 | 266 | 79 | 11 | MM15843 |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 1.38e-06 | 35 | 79 | 5 | MM17219 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 2.41e-06 | 39 | 79 | 5 | MM17212 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 4.98e-06 | 45 | 79 | 5 | MM14912 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 6.90e-06 | 48 | 79 | 5 | MM17214 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.13e-05 | 53 | 79 | 5 | MM15716 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 1.24e-05 | 54 | 79 | 5 | MM14655 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 1.49e-05 | 56 | 79 | 5 | MM14815 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 1.77e-05 | 58 | 79 | 5 | MM14914 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 2.05e-05 | 272 | 79 | 9 | M13380 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 2.09e-05 | 60 | 79 | 5 | MM14913 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 2.09e-05 | 60 | 79 | 5 | MM14872 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | NPSR1 TAAR3P TSHR ADGRE2 BDKRB2 CCKBR ADORA3 P2RY4 GLP1R SCTR LTB4R | 2.61e-05 | 430 | 79 | 11 | MM15160 |
| Pathway | WP_NUCLEOTIDE_GPCRS | 2.71e-05 | 11 | 79 | 3 | M39422 | |
| Pathway | WP_NUCLEOTIDE_GPCRS | 3.59e-05 | 12 | 79 | 3 | MM15953 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | NPSR1 TSHR ADGRE2 BDKRB2 CCKBR ADORA3 TAS2R8 P2RY4 GLP1R SCTR LTB4R | 5.13e-05 | 463 | 79 | 11 | M507 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 8.09e-05 | 186 | 79 | 7 | MM15994 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.06e-04 | 84 | 79 | 5 | MM14653 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | NPSR1 TAAR3P TSHR ADGRE2 BDKRB2 TIAM2 CCKBR ADORA3 P2RY4 GLP1R SCTR LTB4R | 2.37e-04 | 646 | 79 | 12 | MM14962 |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.55e-04 | 158 | 79 | 6 | MM14812 | |
| Pathway | REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT | 3.07e-04 | 5 | 79 | 2 | M27147 | |
| Pathway | WP_TRIACYLGLYCERIDE_SYNTHESIS | 3.15e-04 | 24 | 79 | 3 | M39692 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 3.15e-04 | 24 | 79 | 3 | M39643 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 3.15e-04 | 24 | 79 | 3 | MM15992 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 3.31e-04 | 107 | 79 | 5 | MM14915 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 4.01e-04 | 26 | 79 | 3 | M39784 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 4.43e-04 | 114 | 79 | 5 | MM14814 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 4.50e-04 | 27 | 79 | 3 | M39863 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | NPSR1 TSHR ADGRE2 BDKRB2 TIAM2 CCKBR ADORA3 TAS2R8 P2RY4 GLP1R SCTR LTB4R | 5.04e-04 | 702 | 79 | 12 | M746 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 5.41e-04 | 333 | 79 | 8 | MM14963 | |
| Pathway | WP_SPHINGOLIPID_PATHWAY | 6.17e-04 | 30 | 79 | 3 | M39501 | |
| Pathway | WP_GPCRS_PEPTIDE | 6.33e-04 | 70 | 79 | 4 | MM15959 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 6.39e-04 | 7 | 79 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 6.39e-04 | 7 | 79 | 2 | MM15081 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 6.39e-04 | 7 | 79 | 2 | MM14856 | |
| Pathway | WP_PEPTIDE_GPCRS | 8.21e-04 | 75 | 79 | 4 | M39696 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 8.35e-04 | 131 | 79 | 5 | MM15717 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 8.49e-04 | 8 | 79 | 2 | M27135 | |
| Pathway | REACTOME_ORGANIC_CATION_TRANSPORT | 8.49e-04 | 8 | 79 | 2 | MM15191 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AHR_SIGNALING_PATHWAY | 8.49e-04 | 8 | 79 | 2 | M47513 | |
| Pathway | REACTOME_ABACAVIR_ADME | 8.49e-04 | 8 | 79 | 2 | MM14869 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 9.56e-04 | 135 | 79 | 5 | MM14781 | |
| Pathway | REACTOME_ABACAVIR_ADME | 1.09e-03 | 9 | 79 | 2 | M677 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 1.09e-03 | 9 | 79 | 2 | M39344 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 1.09e-03 | 9 | 79 | 2 | M27143 | |
| Pathway | REACTOME_SPERM_MOTILITY_AND_TAXES | 1.09e-03 | 9 | 79 | 2 | M26935 | |
| Pathway | REACTOME_SPERM_MOTILITY_AND_TAXES | 1.09e-03 | 9 | 79 | 2 | MM14548 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.24e-03 | 143 | 79 | 5 | MM15055 | |
| Pathway | REACTOME_ORGANIC_CATION_TRANSPORT | 1.36e-03 | 10 | 79 | 2 | M27450 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 1.53e-03 | 150 | 79 | 5 | MM14889 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 1.65e-03 | 11 | 79 | 2 | MM14863 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 1.65e-03 | 11 | 79 | 2 | M47812 | |
| Pathway | WP_GPCRS_OTHER | 1.83e-03 | 93 | 79 | 4 | M39629 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.90e-03 | 44 | 79 | 3 | M11911 | |
| Pathway | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | 1.97e-03 | 12 | 79 | 2 | MM15192 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 2.03e-03 | 45 | 79 | 3 | M39615 | |
| Pathway | WP_ESTROGEN_RECEPTOR_PATHWAY | 2.32e-03 | 13 | 79 | 2 | M39496 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 2.44e-03 | 48 | 79 | 3 | MM15902 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.48e-03 | 330 | 79 | 7 | M18334 | |
| Pathway | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | 3.11e-03 | 15 | 79 | 2 | M888 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | CERS2 CYP1A1 CYP1B1 ABCA1 AGPAT4 CERS6 TIAM2 PLPP2 DHCR24 MOGAT3 ACSL5 | 3.19e-03 | 757 | 79 | 11 | M27451 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.36e-03 | 260 | 79 | 6 | M39397 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES | 3.48e-03 | 111 | 79 | 4 | M48065 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 3.54e-03 | 16 | 79 | 2 | M6786 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 3.54e-03 | 16 | 79 | 2 | MM15050 | |
| Pathway | REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING | 3.54e-03 | 16 | 79 | 2 | MM15127 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 3.99e-03 | 57 | 79 | 3 | M39812 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 4.48e-03 | 18 | 79 | 2 | M39424 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 4.61e-03 | 60 | 79 | 3 | MM14964 | |
| Pubmed | Cloning, sequencing and expression of the rearranged MOPC 315 VH gene segment. | 4.11e-12 | 7 | 102 | 5 | 2497341 | |
| Pubmed | 4.11e-12 | 7 | 102 | 5 | 3937730 | ||
| Pubmed | Model-building studies of antigen-binding sites: the hapten-binding site of mopc-315. | 4.11e-12 | 7 | 102 | 5 | 268248 | |
| Pubmed | 4.11e-12 | 7 | 102 | 5 | 2587273 | ||
| Pubmed | Amino acid sequence of the precursor region of MOPC-315 mouse immunoglobulin heavy chain. | 4.11e-12 | 7 | 102 | 5 | 414225 | |
| Pubmed | 4.11e-12 | 7 | 102 | 5 | 4524622 | ||
| Pubmed | A new germline VH36-60 gene is used in the neonatal primary and adult memory response to (T,G)-A--L. | 4.11e-12 | 7 | 102 | 5 | 1683681 | |
| Pubmed | Structure and function of immunoglobulin genes and precursors. | 4.89e-11 | 10 | 102 | 5 | 428562 | |
| Pubmed | Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response. | 4.97e-09 | 22 | 102 | 5 | 2499654 | |
| Pubmed | Chromosomal organization of the human VH4 gene family. Location of individual gene segments. | 9.78e-08 | 4 | 102 | 3 | 8454861 | |
| Pubmed | Activation of ATP-binding cassette transporter A1 transcription by chromatin remodeling complex. | 4.87e-07 | 6 | 102 | 3 | 15774904 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | CERS2 SPNS1 NPSR1 CERS6 TSHR BDKRB2 CCKBR SLC12A5 TMEM62 BCAP29 TRAM1 DHCR24 | 9.97e-07 | 697 | 102 | 12 | 28298427 |
| Pubmed | 2.18e-06 | 200 | 102 | 7 | 18240029 | ||
| Pubmed | IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. | 3.28e-06 | 77 | 102 | 5 | 15608191 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 8670841 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23163725 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12538837 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16949388 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 19995559 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 8.52e-06 | 2 | 102 | 2 | 23076393 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 24535777 | ||
| Pubmed | Expression profile of CYP1A1 and CYP1B1 enzymes in colon and bladder tumors. | 8.52e-06 | 2 | 102 | 2 | 24358191 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17919675 | ||
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 8.52e-06 | 2 | 102 | 2 | 9603422 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15576411 | ||
| Pubmed | Increased expression of CYP1A1 and CYP1B1 in ovarian/peritoneal endometriotic lesions. | 8.52e-06 | 2 | 102 | 2 | 27012269 | |
| Pubmed | 3-Hydroxyglutaric acid is transported via the sodium-dependent dicarboxylate transporter NaDC3. | 8.52e-06 | 2 | 102 | 2 | 17356845 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23047765 | ||
| Pubmed | CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. | 8.52e-06 | 2 | 102 | 2 | 18763031 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23276717 | ||
| Pubmed | Connexin50 couples axon terminals of mouse horizontal cells by homotypic gap junctions. | 8.52e-06 | 2 | 102 | 2 | 25823610 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 27097303 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15240517 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 8.52e-06 | 2 | 102 | 2 | 33027072 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 28038711 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 27179782 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23872584 | ||
| Pubmed | Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. | 8.52e-06 | 2 | 102 | 2 | 23963727 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16581093 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12493776 | ||
| Pubmed | Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4. | 8.52e-06 | 2 | 102 | 2 | 31375262 | |
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 8.52e-06 | 2 | 102 | 2 | 23088494 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17075831 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20333683 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 34812766 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16051642 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18779756 | ||
| Pubmed | Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma. | 8.52e-06 | 2 | 102 | 2 | 32855269 | |
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 8.52e-06 | 2 | 102 | 2 | 30478150 | |
| Pubmed | Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. | 8.52e-06 | 2 | 102 | 2 | 22721696 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18508913 | ||
| Pubmed | Association of CYP1A1 and CYP1B1 inhibition in in vitro assays with drug-induced liver injury. | 8.52e-06 | 2 | 102 | 2 | 33814510 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 11719516 | ||
| Pubmed | Expression profile of CYP1A1 and CYP1B1 enzymes in endometrial tumors. | 8.52e-06 | 2 | 102 | 2 | 24957043 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15596250 | ||
| Pubmed | Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress. | 8.52e-06 | 2 | 102 | 2 | 19126602 | |
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 8.52e-06 | 2 | 102 | 2 | 25808524 | |
| Pubmed | Associations of CYP1 polymorphisms with risk of prostate cancer: an updated meta-analysis. | 8.52e-06 | 2 | 102 | 2 | 30765615 | |
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 8.52e-06 | 2 | 102 | 2 | 19144648 | |
| Pubmed | DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes. | 8.52e-06 | 2 | 102 | 2 | 28706277 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 14734460 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 21092585 | ||
| Pubmed | Protein expression of ABCC2 and SLC22A3 associates with prognosis of pancreatic adenocarcinoma. | 8.52e-06 | 2 | 102 | 2 | 31874997 | |
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 8.52e-06 | 2 | 102 | 2 | 29391527 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 37634210 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 26551623 | ||
| Pubmed | Cytochrome 1A1 and 1B1 gene diversity in the Zanzibar islands. | 8.52e-06 | 2 | 102 | 2 | 22594779 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 19458193 | ||
| Pubmed | Gene structures of the human non-neuronal monoamine transporters EMT and OCT2. | 8.52e-06 | 2 | 102 | 2 | 10942111 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 28560433 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 8208605 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 34289068 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 34518526 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 32312722 | ||
| Pubmed | CYP1B1, but not CYP1A1, is downregulated by promoter methylation in colorectal cancers. | 8.52e-06 | 2 | 102 | 2 | 19287966 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 26356327 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 11955671 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17174438 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 19912991 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15582647 | ||
| Pubmed | Modulation of CYP1A1, CYP1B1 and DNA adducts level by green and white tea in Balb/c mice. | 8.52e-06 | 2 | 102 | 2 | 22960141 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17449539 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12566296 | ||
| Pubmed | A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. | 8.52e-06 | 2 | 102 | 2 | 11163203 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25304467 | ||
| Pubmed | Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. | 8.52e-06 | 2 | 102 | 2 | 12620226 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 31406271 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 27039070 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 28300467 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 29848589 | ||
| Pubmed | Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits. | 8.52e-06 | 2 | 102 | 2 | 29273066 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 19424633 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 11577022 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 1.69e-05 | 499 | 102 | 9 | 22810586 | |
| Pubmed | 1.94e-05 | 18 | 102 | 3 | 15081111 | ||
| Pubmed | The novel mouse connexin39 gene is expressed in developing striated muscle fibers. | 1.94e-05 | 18 | 102 | 3 | 15466892 | |
| Pubmed | An update on connexin genes and their nomenclature in mouse and man. | 2.29e-05 | 19 | 102 | 3 | 14681012 | |
| Pubmed | 2.34e-05 | 193 | 102 | 6 | 19343046 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 28292935 | ||
| Interaction | TTYH1 interactions | CERS2 SLC12A6 TMEM60 AGPAT4 CERS6 SLC35F1 TMEM62 BCAP29 DHCR24 ABCD4 TMEM68 | 1.09e-07 | 300 | 91 | 11 | int:TTYH1 |
| Interaction | KIR2DL3 interactions | 4.78e-07 | 65 | 91 | 6 | int:KIR2DL3 | |
| Interaction | ULBP3 interactions | 4.46e-06 | 54 | 91 | 5 | int:ULBP3 | |
| Interaction | AQP6 interactions | SLC66A2 TMEM60 AGPAT4 SLC35F1 ADGRE2 ANKRD46 SLC38A7 EMD ACSL5 | 1.83e-05 | 330 | 91 | 9 | int:AQP6 |
| Interaction | SLC35C2 interactions | 2.50e-05 | 128 | 91 | 6 | int:SLC35C2 | |
| Interaction | YIF1A interactions | 2.61e-05 | 129 | 91 | 6 | int:YIF1A | |
| Interaction | HTR2C interactions | 2.73e-05 | 130 | 91 | 6 | int:HTR2C | |
| Interaction | LPAR1 interactions | 4.66e-05 | 210 | 91 | 7 | int:LPAR1 | |
| Interaction | SCN3B interactions | 5.25e-05 | 214 | 91 | 7 | int:SCN3B | |
| Interaction | TMEM63B interactions | 5.44e-05 | 147 | 91 | 6 | int:TMEM63B | |
| Interaction | TMEM63A interactions | 1.04e-04 | 103 | 91 | 5 | int:TMEM63A | |
| Interaction | NHERF4 interactions | 1.29e-04 | 22 | 91 | 3 | int:NHERF4 | |
| Interaction | LMAN2L interactions | 1.48e-04 | 111 | 91 | 5 | int:LMAN2L | |
| Interaction | GPR42 interactions | 1.48e-04 | 111 | 91 | 5 | int:GPR42 | |
| Interaction | SLC10A6 interactions | 1.61e-04 | 179 | 91 | 6 | int:SLC10A6 | |
| Interaction | DRD2 interactions | 1.67e-04 | 114 | 91 | 5 | int:DRD2 | |
| Interaction | FAM209A interactions | 1.81e-04 | 261 | 91 | 7 | int:FAM209A | |
| Interaction | YIPF6 interactions | 1.89e-04 | 117 | 91 | 5 | int:YIPF6 | |
| Interaction | SLC10A1 interactions | 2.21e-04 | 121 | 91 | 5 | int:SLC10A1 | |
| Interaction | POMK interactions | 2.28e-04 | 271 | 91 | 7 | int:POMK | |
| Interaction | GPX8 interactions | 2.38e-04 | 273 | 91 | 7 | int:GPX8 | |
| Interaction | NPC1 interactions | 2.42e-04 | 364 | 91 | 8 | int:NPC1 | |
| Interaction | VIPR2 interactions | 2.49e-04 | 194 | 91 | 6 | int:VIPR2 | |
| Interaction | TSPAN15 interactions | 2.54e-04 | 276 | 91 | 7 | int:TSPAN15 | |
| Interaction | TNFSF18 interactions | 2.69e-04 | 69 | 91 | 4 | int:TNFSF18 | |
| Interaction | SLC35E3 interactions | 2.69e-04 | 28 | 91 | 3 | int:SLC35E3 | |
| Interaction | GPR152 interactions | 2.78e-04 | 198 | 91 | 6 | int:GPR152 | |
| Interaction | SLC15A4 interactions | 2.99e-04 | 29 | 91 | 3 | int:SLC15A4 | |
| Interaction | MMGT1 interactions | 3.29e-04 | 381 | 91 | 8 | int:MMGT1 | |
| Interaction | SLC35A4 interactions | 3.31e-04 | 30 | 91 | 3 | int:SLC35A4 | |
| Interaction | TMEM169 interactions | 3.52e-04 | 74 | 91 | 4 | int:TMEM169 | |
| Interaction | HSD17B11 interactions | 3.84e-04 | 390 | 91 | 8 | int:HSD17B11 | |
| Interaction | LEPROTL1 interactions | 4.09e-04 | 77 | 91 | 4 | int:LEPROTL1 | |
| Interaction | KCNK5 interactions | 4.41e-04 | 33 | 91 | 3 | int:KCNK5 | |
| Cytoband | 14q32.33 | IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-30-2 IGHV4-28 IGHV4-4 | 4.80e-08 | 228 | 102 | 8 | 14q32.33 |
| Cytoband | 19p13.1 | 1.71e-04 | 48 | 102 | 3 | 19p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q32 | BDKRB2 SERPINA11 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28 IGHV4-4 | 2.81e-04 | 566 | 102 | 7 | chr14q32 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 1.49e-03 | 219 | 102 | 4 | chr7q22 | |
| Cytoband | 6q22.31 | 1.65e-03 | 27 | 102 | 2 | 6q22.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q23 | 1.67e-03 | 226 | 102 | 4 | chr1q23 | |
| Cytoband | 8q12.1 | 1.91e-03 | 29 | 102 | 2 | 8q12.1 | |
| Cytoband | 7q22.1 | 2.09e-03 | 113 | 102 | 3 | 7q22.1 | |
| Cytoband | 6q25.3 | 2.47e-03 | 33 | 102 | 2 | 6q25.3 | |
| Cytoband | 10q24 | 2.77e-03 | 35 | 102 | 2 | 10q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q22 | 2.91e-03 | 127 | 102 | 3 | chr6q22 | |
| Cytoband | 1q23.1 | 4.75e-03 | 46 | 102 | 2 | 1q23.1 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-30-2 IGHV4-28 IGHV4-4 | 2.51e-06 | 187 | 84 | 8 | 349 |
| GeneFamily | Solute carriers | SLC12A6 SLC13A3 SLC35F1 SLC12A5 SLC39A12 SLC22A3 SLC22A2 SLC38A7 SLC45A2 | 8.98e-05 | 395 | 84 | 9 | 752 |
| GeneFamily | Cytochrome P450 family 1 | 1.27e-04 | 4 | 84 | 2 | 1000 | |
| GeneFamily | Gap junction proteins | 1.40e-04 | 22 | 84 | 3 | 314 | |
| GeneFamily | CERS class homeoboxes | 3.16e-04 | 6 | 84 | 2 | 530 | |
| GeneFamily | Glucagon receptor family | 3.16e-04 | 6 | 84 | 2 | 269 | |
| GeneFamily | 7TM orphan receptors | 3.16e-04 | 6 | 84 | 2 | 310 | |
| GeneFamily | Neuropeptide receptors | 9.37e-04 | 10 | 84 | 2 | 854 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 9.74e-04 | 42 | 84 | 3 | 602 | |
| Coexpression | PRC2_EED_DN.V1_UP | 7.22e-06 | 191 | 97 | 7 | M2736 | |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 2.89e-06 | 176 | 100 | 6 | 50e207403d48ce1b55a78897adb5519a2430a626 | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.29e-06 | 180 | 100 | 6 | 6a777a308fa3160d31eda468db930e71862020b2 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma|Liver / Manually curated celltypes from each tissue | 3.98e-06 | 186 | 100 | 6 | a2c7430781f432c9c90ac4d620f4518ff767a223 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.10e-06 | 187 | 100 | 6 | 11670a85db87cbb3e78022a589632173604b0940 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.10e-06 | 187 | 100 | 6 | 0277d4e54bd4d48f30241c2951a569209423fee8 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 4.10e-06 | 187 | 100 | 6 | 5429ae85942b8ec3895cceb63c663de3c24ca064 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 4.36e-06 | 189 | 100 | 6 | 8030a353473da34ae92429f2d822171a2e94248f | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.92e-06 | 193 | 100 | 6 | 7b4b0271e4fbece703876acb053ae236afb7cdba | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-06 | 195 | 100 | 6 | 13f4ee21568fd747608412d33559d10561dbb3c8 | |
| ToppCell | Biopsy_Other_PF-Immune-Plasma_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.22e-06 | 195 | 100 | 6 | d0305c6a68c9e361507b04db94f86873085d49b3 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-06 | 196 | 100 | 6 | c38e7f533c619afe008de0e99042f7180c2da918 | |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 5.37e-06 | 196 | 100 | 6 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-06 | 196 | 100 | 6 | fec21383435779bf4c632decd3d29c6ca7baebfb | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.53e-06 | 197 | 100 | 6 | 1e63879633f20646e44873ae6b662f6faf4806fd | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.53e-06 | 197 | 100 | 6 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.69e-06 | 198 | 100 | 6 | 85215015bb86ada0e871c413a4ecdc903a3785ca | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.69e-06 | 198 | 100 | 6 | 38349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.86e-06 | 199 | 100 | 6 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-06 | 199 | 100 | 6 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | distal-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.86e-06 | 199 | 100 | 6 | 21b44031bc5182ee23ba5e206042b2e5e4ee0c3c | |
| ToppCell | distal-Epithelial-Signaling_Alveolar_Epithelial_Type_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.03e-06 | 200 | 100 | 6 | f47bb79202a59404e4916993a1f59cffcf710320 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.03e-06 | 200 | 100 | 6 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-06 | 200 | 100 | 6 | 23088edc62bf7d4db890937bfd7925dc316fcc76 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.03e-06 | 200 | 100 | 6 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.03e-06 | 200 | 100 | 6 | ad9cdc82a647d379abc713a56db0e11bb6494106 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-06 | 200 | 100 | 6 | b2d61bc3afac0d78aa30082760da5b1a15d1fad2 | |
| ToppCell | distal-Epithelial-Signaling_Alveolar_Epithelial_Type_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.03e-06 | 200 | 100 | 6 | b0e5c8b425f47833cdc00b5aa3734c8c980f0967 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.03e-06 | 200 | 100 | 6 | 95b9cc2d6f18d8c3ece933e5537c16e1b7137b34 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.22e-05 | 73 | 100 | 4 | 582faedb369a099d0acf1565413e6b3ca2cfc564 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 155 | 100 | 5 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 160 | 100 | 5 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.65e-05 | 166 | 100 | 5 | 2b7b580bec8d9467b0deaf97098065f72dbf2a4f | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 168 | 100 | 5 | d72cd8238fa793bb3e4add4c59eaaaadcea9930d | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 168 | 100 | 5 | c34c52165485f612add7a3e35a175d5a6e365e7c | |
| ToppCell | facs-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 168 | 100 | 5 | d2afc097ae1243574210be6a751685f949ea941a | |
| ToppCell | TCGA-Brain|World / Sample_Type by Project: Shred V9 | 4.09e-05 | 170 | 100 | 5 | f78e360a6a44d599ec0d207cba4704e50aa314f8 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 170 | 100 | 5 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 170 | 100 | 5 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.45e-05 | 173 | 100 | 5 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.57e-05 | 174 | 100 | 5 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.96e-05 | 177 | 100 | 5 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 4.96e-05 | 177 | 100 | 5 | 22b7cda748cf5e665be54ca5bae89f0c130d5e7f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.09e-05 | 178 | 100 | 5 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.51e-05 | 181 | 100 | 5 | e47664a264a2c37390d1668ce04eef2e0172f4cb | |
| ToppCell | AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.51e-05 | 181 | 100 | 5 | ed0ea67f0607073aedf153f8d1073b35e46127c3 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.52e-05 | 92 | 100 | 4 | bbaf5a131f860198840e34843b7c841bcc98d9c4 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.52e-05 | 92 | 100 | 4 | e6aa2b8ca9235a7291ee41d976b886fec185835d | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 5.66e-05 | 182 | 100 | 5 | 27d1688fdfc570cedd233aa7030bce7d9b604d42 | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.80e-05 | 183 | 100 | 5 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 5.96e-05 | 184 | 100 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 6.11e-05 | 185 | 100 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.11e-05 | 185 | 100 | 5 | 01d0e848d8ede2745cfb10b070e2d9674ef4d477 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.11e-05 | 185 | 100 | 5 | 08bc817908076734d66f2805cb954141f2cc5a18 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.11e-05 | 185 | 100 | 5 | 1704a12153a9b107bf03ecccd1a036cf61334d7a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.27e-05 | 186 | 100 | 5 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.27e-05 | 186 | 100 | 5 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.43e-05 | 187 | 100 | 5 | c80e03d5aa498b4eecbc46565fabf9b5be10c71c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.43e-05 | 187 | 100 | 5 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class | 6.43e-05 | 187 | 100 | 5 | 19d6a404fc3651d98a93e3848e372df51a239c57 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-05 | 187 | 100 | 5 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-05 | 187 | 100 | 5 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 6.59e-05 | 188 | 100 | 5 | bd53b0371154cff680226897b61c9809a239d1b6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-05 | 188 | 100 | 5 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.59e-05 | 188 | 100 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-05 | 188 | 100 | 5 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.76e-05 | 189 | 100 | 5 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.76e-05 | 189 | 100 | 5 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.93e-05 | 190 | 100 | 5 | 76b747bafff09bf8375a5717c9f213cbfb405bac | |
| ToppCell | (7)_Epithelial-D_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.93e-05 | 190 | 100 | 5 | 832d6d3ad14665e50623afe1b8586ccae1a97de5 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.93e-05 | 190 | 100 | 5 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.93e-05 | 190 | 100 | 5 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 7.11e-05 | 191 | 100 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.46e-05 | 193 | 100 | 5 | 8646e573f2d2ff175f3d02bfdf214e65f3b614d3 | |
| ToppCell | medial-2-Hematologic-EREG+_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.65e-05 | 194 | 100 | 5 | b2b4e4c3ac0df0d9f17b930ffb60c0fd85b3dd78 | |
| ToppCell | medial-Hematologic-EREG+_Dendritic-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.65e-05 | 194 | 100 | 5 | 15f3b6b6579e388d0820f05e93a77ee1634bd6c3 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.65e-05 | 194 | 100 | 5 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 | |
| ToppCell | medial-Hematologic-EREG+_Dendritic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.65e-05 | 194 | 100 | 5 | 1f3d22292d2691f93aa7b6770f5c250a33db3cc0 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 7.65e-05 | 194 | 100 | 5 | e2d9186a7e8d1a4a71d7bd6dba7fc955d55479e6 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-05 | 195 | 100 | 5 | f3f7f1a77a1edd2b50a8211c76fe289738eb04cf | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-05 | 195 | 100 | 5 | df009b18898c10686f75cf72b4ec0eff18f5bb50 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-DC2|lymph-node_spleen / Manually curated celltypes from each tissue | 8.03e-05 | 196 | 100 | 5 | 9666b5380e2b2a3c3b56a8c769817a1df8820ed6 | |
| ToppCell | (7)_Epithelial-B_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.03e-05 | 196 | 100 | 5 | 345d4cc062b43bca9d506fbf23363469a9ba496f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.03e-05 | 196 | 100 | 5 | 77feb22fd0b0b1df03375da472134412e9e69c90 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.03e-05 | 196 | 100 | 5 | 784459f9f3614ead947aeb61a873dfd4cbe50641 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.22e-05 | 197 | 100 | 5 | 0d59a2669de60046e8140d82e67c2b5da4a5683c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.22e-05 | 197 | 100 | 5 | 87c4eafe46f622f9830df75e1ca589e064651db4 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.22e-05 | 197 | 100 | 5 | d8355f07a53e771052f9ab6b38814365dfe8d9ae | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-05 | 197 | 100 | 5 | 7b12f9d4ad1e84df58e86591a491c84d4f36eac5 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.22e-05 | 197 | 100 | 5 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c | |
| ToppCell | medial-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.42e-05 | 198 | 100 | 5 | 102a4cbb138adbfba11ed955420095daa098532f | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.42e-05 | 198 | 100 | 5 | 7caeed2d5dc78866023c8f38edcec9886baa9f2c | |
| ToppCell | ASK428-Epithelial-Type_2|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.42e-05 | 198 | 100 | 5 | ec0d1801363adb70c6a26655b79d12b438c7417d | |
| ToppCell | Monocytes|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.42e-05 | 198 | 100 | 5 | 8beccf03c9ec9cd02a96107a9d7ca9a6764c6a61 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.42e-05 | 198 | 100 | 5 | 1fe51f4beca0eef4ff117e6edaa646e35c0f9629 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.42e-05 | 198 | 100 | 5 | 79c690d21d3420d0bb1a3b3b4ea2c9aa3810a219 | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.42e-05 | 198 | 100 | 5 | 53e5d76831d70b9a476f3ef3a81e13eda974d543 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(4)_1wkpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 8.58e-05 | 103 | 100 | 4 | 942cc6f9699f777638e59aee40a402a16fdbb2e7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-05 | 199 | 100 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.62e-05 | 199 | 100 | 5 | b44d74895846e2ac144438b73e0ca91e3949c16c | |
| ToppCell | Control-Control-Lymphocyte-B-Plasmablast|Control / Disease, condition lineage and cell class | 8.62e-05 | 199 | 100 | 5 | c11aa8bca3723a886e7082ae48bb922dd8396be4 | |
| Computational | Genes in the cancer module 27. | 1.80e-04 | 355 | 49 | 8 | MODULE_27 | |
| Computational | Genes in the cancer module 367. | 2.99e-04 | 29 | 49 | 3 | MODULE_367 | |
| Drug | PCB39 | 7.04e-08 | 3 | 95 | 3 | CID000038038 | |
| Drug | AC1L3Z73 | 1.39e-06 | 6 | 95 | 3 | CID000097765 | |
| Drug | N-benzyl-1-aminobenzotriazole | 2.43e-06 | 7 | 95 | 3 | CID000004309 | |
| Drug | AC1L2JFQ | 2.83e-06 | 24 | 95 | 4 | CID000073197 | |
| Drug | 5-methylchrysene-1,2-diol | 3.88e-06 | 8 | 95 | 3 | CID010731025 | |
| Drug | benzo(b)fluoranthene | 3.96e-06 | 26 | 95 | 4 | CID000009153 | |
| Drug | 7-ethoxy-4-trifluoromethylcoumarin | 4.64e-06 | 27 | 95 | 4 | CID000130779 | |
| Drug | 5,6,7,8-tetrahydroindolizine | 5.80e-06 | 9 | 95 | 3 | CID000577683 | |
| Drug | Propranolol | 6.45e-06 | 109 | 95 | 6 | ctd:D011433 | |
| Drug | 9-ethynylphenanthrene | 8.27e-06 | 10 | 95 | 3 | CID000182098 | |
| Drug | NSC 60593 | 8.27e-06 | 10 | 95 | 3 | CID000089340 | |
| Drug | dibenz(a,h)anthracene | 1.06e-05 | 33 | 95 | 4 | CID000005889 | |
| Drug | desethylamodiaquine | 1.13e-05 | 11 | 95 | 3 | CID000122068 | |
| Drug | 1-methylphenanthrene | 1.13e-05 | 11 | 95 | 3 | CID000013257 | |
| Drug | eugenol | 1.37e-05 | 73 | 95 | 5 | CID000003314 | |
| Drug | alpha MB | 1.51e-05 | 12 | 95 | 3 | CID000119340 | |
| Drug | rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.66e-05 | 193 | 95 | 7 | 921_UP | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.72e-05 | 194 | 95 | 7 | 3285_UP | |
| Drug | SK&F 550 | 1.72e-05 | 2 | 95 | 2 | ctd:C102994 | |
| Drug | 6-prenylnaringenin | 1.72e-05 | 2 | 95 | 2 | ctd:C521871 | |
| Drug | cirsiliol | 1.72e-05 | 2 | 95 | 2 | ctd:C039824 | |
| Drug | disprocynium 24 | 1.72e-05 | 2 | 95 | 2 | ctd:C103851 | |
| Drug | 6-(4-diethylamino)phenyl-7-chloro-5,8-quinolinedione | 1.72e-05 | 2 | 95 | 2 | ctd:C454039 | |
| Drug | 6-hydroxyluteolin | 1.72e-05 | 2 | 95 | 2 | ctd:C057617 | |
| Drug | 5-androstene-16-fluoro-17-one | 1.72e-05 | 2 | 95 | 2 | ctd:C106219 | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | 1.83e-05 | 196 | 95 | 7 | 7128_UP | |
| Drug | formononetin | 1.88e-05 | 38 | 95 | 4 | ctd:C007768 | |
| Drug | benzyloxyresorufin | 1.89e-05 | 78 | 95 | 5 | CID000114982 | |
| Drug | Tyloxapol [25301-02-4]; Down 200; 4uM; MCF7; HT_HG-U133A | 1.90e-05 | 197 | 95 | 7 | 5672_DN | |
| Drug | rhapontigenin | 1.95e-05 | 13 | 95 | 3 | CID005320954 | |
| Drug | 5-hydroxythiabendazole | 1.95e-05 | 13 | 95 | 3 | CID000108227 | |
| Drug | PCB 81 | 1.95e-05 | 13 | 95 | 3 | CID000051043 | |
| Drug | chrysophanic acid | 1.95e-05 | 13 | 95 | 3 | ctd:C027113 | |
| Drug | CMV423 | 1.95e-05 | 13 | 95 | 3 | CID000489128 | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 4351_UP | |
| Drug | Proglumide [6620-60-6]; Up 200; 12uM; PC3; HT_HG-U133A | 2.02e-05 | 199 | 95 | 7 | 3780_UP | |
| Drug | 5,7-dimethoxyflavone | 2.48e-05 | 14 | 95 | 3 | CID000088881 | |
| Drug | AC1L2476 | 2.48e-05 | 14 | 95 | 3 | CID000014611 | |
| Drug | aniline | 2.92e-05 | 142 | 95 | 6 | CID000006115 | |
| Drug | 7-ethoxycoumarin | 3.03e-05 | 86 | 95 | 5 | CID000035703 | |
| Drug | 2-ethynylnaphthalene | 3.09e-05 | 15 | 95 | 3 | CID000115017 | |
| Drug | erucin | 3.09e-05 | 15 | 95 | 3 | ctd:C073539 | |
| Drug | pentoxyresorufin | 3.21e-05 | 87 | 95 | 5 | CID000107683 | |
| Drug | AC1L1AH5 | 3.32e-05 | 215 | 95 | 7 | CID000000986 | |
| Drug | quindine | 3.73e-05 | 219 | 95 | 7 | CID000001065 | |
| Drug | isoimperatorin | 3.79e-05 | 16 | 95 | 3 | ctd:C055542 | |
| Drug | PCB 118 | 3.79e-05 | 16 | 95 | 3 | CID000035823 | |
| Drug | fluasterone | 4.59e-05 | 17 | 95 | 3 | CID000133967 | |
| Drug | ethoxyresorufin | 4.90e-05 | 95 | 95 | 5 | CID000003294 | |
| Drug | dibenzo(a,e)pyrene | 5.15e-05 | 3 | 95 | 2 | ctd:C041516 | |
| Drug | 2,4,5,3',4',5'-hexachlorobiphenyl | 5.15e-05 | 3 | 95 | 2 | ctd:C038372 | |
| Drug | 2-amino-1,7-dimethylimidazo(4,5-g)quinoxaline | 5.15e-05 | 3 | 95 | 2 | ctd:C519626 | |
| Drug | scutellarein | 5.15e-05 | 3 | 95 | 2 | ctd:C458179 | |
| Drug | genkwanin | 5.15e-05 | 3 | 95 | 2 | ctd:C014568 | |
| Drug | 1-methoxyrutaecarpine | 5.15e-05 | 3 | 95 | 2 | CID005319487 | |
| Drug | 8-methylbenzanthracene | 5.15e-05 | 3 | 95 | 2 | ctd:C031255 | |
| Drug | 6-methylbenzo(a)pyrene | 5.15e-05 | 3 | 95 | 2 | ctd:C017503 | |
| Drug | 1-(1-propynyl)pyrene | 5.15e-05 | 3 | 95 | 2 | ctd:C402363 | |
| Drug | 4-methylbenz(a)anthracene | 5.15e-05 | 3 | 95 | 2 | ctd:C040143 | |
| Drug | 6-methylbenz(a)anthracene | 5.15e-05 | 3 | 95 | 2 | ctd:C046305 | |
| Drug | 2,2',4,6'-tetramethoxystilbene | 5.15e-05 | 3 | 95 | 2 | ctd:C541980 | |
| Drug | 2-methylbenz(a)anthracene | 5.15e-05 | 3 | 95 | 2 | ctd:C047719 | |
| Drug | 5-methylbenzanthracene | 5.15e-05 | 3 | 95 | 2 | ctd:C035724 | |
| Drug | 2-methyl-5-isopropenylcyclohex-2-enone oxime | 5.15e-05 | 3 | 95 | 2 | ctd:C540395 | |
| Drug | 2,3,4,5,3',4',5'-heptachlorobiphenyl | 5.15e-05 | 3 | 95 | 2 | ctd:C034559 | |
| Drug | 6-nitrobenzo(a)pyrene | 5.15e-05 | 3 | 95 | 2 | ctd:C034699 | |
| Drug | 2-ethynylpyrene | 5.15e-05 | 3 | 95 | 2 | CID010846871 | |
| Drug | 11-methylbenzanthracene | 5.15e-05 | 3 | 95 | 2 | ctd:C034041 | |
| Drug | 1-methylbenz(a)anthracene | 5.15e-05 | 3 | 95 | 2 | ctd:C022032 | |
| Drug | DB04103 | 5.41e-05 | 97 | 95 | 5 | CID004469987 | |
| Drug | PX-12 | 5.49e-05 | 18 | 95 | 3 | CID000219104 | |
| Drug | Primaquine | 5.49e-05 | 18 | 95 | 3 | ctd:D011319 | |
| Drug | 1-ethynylpyrene | 5.49e-05 | 18 | 95 | 3 | CID000154905 | |
| Drug | 2-nitrofluoranthene | 5.49e-05 | 18 | 95 | 3 | CID000025760 | |
| Drug | AC1LCF1F | 5.89e-05 | 161 | 95 | 6 | CID000627275 | |
| Drug | pantoprazole | 6.50e-05 | 19 | 95 | 3 | ctd:C064276 | |
| Drug | 6-aminochrysene | 6.50e-05 | 19 | 95 | 3 | CID000017534 | |
| Drug | omeprazole | 6.57e-05 | 101 | 95 | 5 | CID000004594 | |
| Drug | L000058 | 7.62e-05 | 20 | 95 | 3 | CID004469580 | |
| Drug | benzo(a)pyrene-7,8-dione | 7.62e-05 | 20 | 95 | 3 | CID000105020 | |
| Drug | Verapamil | 7.90e-05 | 105 | 95 | 5 | ctd:D014700 | |
| Drug | orphenadrine | 8.85e-05 | 56 | 95 | 4 | CID000004601 | |
| Drug | Quinidine | 8.85e-05 | 56 | 95 | 4 | ctd:D011802 | |
| Drug | 4-methoxyestradiol | 8.86e-05 | 21 | 95 | 3 | CID000068578 | |
| Drug | dibenz(a,c)anthracene | 8.86e-05 | 21 | 95 | 3 | CID000009164 | |
| Drug | 2-naphthylamine | 9.85e-05 | 110 | 95 | 5 | CID000007057 | |
| Drug | 6-nitrochrysene | 1.02e-04 | 22 | 95 | 3 | CID000024121 | |
| Drug | imperatorin | 1.02e-04 | 22 | 95 | 3 | ctd:C031534 | |
| Drug | Quinine | 1.02e-04 | 22 | 95 | 3 | ctd:D011803 | |
| Drug | 1-chloropyrene | 1.03e-04 | 4 | 95 | 2 | ctd:C040345 | |
| Drug | AC1O5183 | 1.03e-04 | 4 | 95 | 2 | CID006426123 | |
| Drug | purpurin | 1.03e-04 | 4 | 95 | 2 | ctd:C511975 | |
| Drug | 2-nitrofluoranthene | 1.03e-04 | 4 | 95 | 2 | ctd:C049030 | |
| Drug | 1,2,3,4,6,7,8-heptachlorodibenzofuran | 1.03e-04 | 4 | 95 | 2 | ctd:C473650 | |
| Drug | 7-methoxyresorufin | 1.03e-04 | 4 | 95 | 2 | ctd:C076580 | |
| Drug | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester | 1.03e-04 | 4 | 95 | 2 | ctd:C520611 | |
| Drug | benzo(j)fluoranthene | 1.03e-04 | 4 | 95 | 2 | ctd:C027704 | |
| Drug | 2-ethynylanthracene | 1.03e-04 | 4 | 95 | 2 | CID000157149 | |
| Drug | 1,4-dihydroxy-2-naphthoic acid | 1.03e-04 | 4 | 95 | 2 | ctd:C024023 | |
| Drug | 1-benzylimidazole | 1.03e-04 | 4 | 95 | 2 | ctd:C017062 | |
| Disease | angiostatin measurement | 6.02e-07 | 6 | 93 | 3 | EFO_0008024 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 1.05e-06 | 7 | 93 | 3 | EFO_0004614, EFO_0006925 | |
| Disease | total lipids in lipoprotein particles measurement | 1.62e-05 | 48 | 93 | 4 | EFO_0022309 | |
| Disease | lipoprotein A measurement | 2.87e-05 | 112 | 93 | 5 | EFO_0006925 | |
| Disease | Colorectal Carcinoma | CYP1B1 ABCA1 SLC66A2 SLC12A5 ADORA3 ABCD4 ABCC2 RNF182 ACSL5 SCN3B | 7.46e-05 | 702 | 93 | 10 | C0009402 |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 7.87e-05 | 224 | 93 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 9.77e-05 | 5 | 93 | 2 | C3281201 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.28e-04 | 31 | 93 | 3 | EFO_0022249 | |
| Disease | systolic blood pressure, body mass index | 1.69e-04 | 34 | 93 | 3 | EFO_0004340, EFO_0006335 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.69e-04 | 34 | 93 | 3 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.69e-04 | 34 | 93 | 3 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | epilepsy (implicated_via_orthology) | 1.70e-04 | 163 | 93 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | creatinine measurement, chronic kidney disease | 1.84e-04 | 35 | 93 | 3 | EFO_0003884, EFO_0004518 | |
| Disease | duodenal ulcer | 2.01e-04 | 36 | 93 | 3 | EFO_0004607 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.18e-04 | 42 | 93 | 3 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | triglycerides in large LDL measurement | 3.41e-04 | 43 | 93 | 3 | EFO_0022319 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 3.49e-04 | 9 | 93 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.89e-04 | 195 | 93 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | metabolite measurement | 3.97e-04 | 560 | 93 | 8 | EFO_0004725 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.17e-04 | 46 | 93 | 3 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | total lipids in small LDL | 4.44e-04 | 47 | 93 | 3 | EFO_0022168 | |
| Disease | free cholesterol in medium VLDL measurement | 4.44e-04 | 47 | 93 | 3 | EFO_0022269 | |
| Disease | Drug habituation | 4.89e-04 | 115 | 93 | 4 | C0013170 | |
| Disease | Drug abuse | 4.89e-04 | 115 | 93 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.89e-04 | 115 | 93 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 4.89e-04 | 115 | 93 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 4.89e-04 | 115 | 93 | 4 | C0013222 | |
| Disease | Drug Dependence | 4.89e-04 | 115 | 93 | 4 | C1510472 | |
| Disease | Substance Dependence | 4.89e-04 | 115 | 93 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 4.89e-04 | 115 | 93 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.89e-04 | 115 | 93 | 4 | C0029231 | |
| Disease | Substance abuse problem | 5.06e-04 | 116 | 93 | 4 | C0740858 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 5.39e-04 | 118 | 93 | 4 | EFO_0010119 | |
| Disease | phospholipids in medium VLDL measurement | 5.99e-04 | 52 | 93 | 3 | EFO_0022154 | |
| Disease | cholesterol in small VLDL measurement | 6.33e-04 | 53 | 93 | 3 | EFO_0022228 | |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 6.86e-04 | 221 | 93 | 5 | C0011860 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 7.43e-04 | 225 | 93 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | Coffin-Siris syndrome | 7.49e-04 | 13 | 93 | 2 | C0265338 | |
| Disease | phospholipids:total lipids ratio | 7.73e-04 | 227 | 93 | 5 | EFO_0020946 | |
| Disease | polyunsaturated fatty acid measurement | 7.98e-04 | 131 | 93 | 4 | EFO_0010733 | |
| Disease | phospholipids in small VLDL measurement | 9.11e-04 | 60 | 93 | 3 | EFO_0022146 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 9.74e-04 | 239 | 93 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | melanoma | 1.15e-03 | 248 | 93 | 5 | C0025202 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 1.30e-03 | 17 | 93 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | banks of the superior temporal sulcus volume measurement | 1.30e-03 | 17 | 93 | 2 | EFO_0010286 | |
| Disease | cholesteryl ester measurement | 1.34e-03 | 257 | 93 | 5 | EFO_0010351 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.41e-03 | 260 | 93 | 5 | EFO_0008317 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.42e-03 | 153 | 93 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.42e-03 | 153 | 93 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | nevus count | 1.45e-03 | 18 | 93 | 2 | EFO_0004632 | |
| Disease | metabolite measurement, diet measurement | 1.48e-03 | 71 | 93 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | inflammatory bowel disease (is_implicated_in) | 1.62e-03 | 19 | 93 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.78e-03 | 274 | 93 | 5 | EFO_0004530, EFO_0004612 | |
| Disease | Colorectal Neoplasms | 1.87e-03 | 277 | 93 | 5 | C0009404 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.91e-03 | 166 | 93 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | triglyceride measurement, body fat percentage | 1.98e-03 | 21 | 93 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | chronic myeloid leukemia (is_implicated_in) | 1.98e-03 | 21 | 93 | 2 | DOID:8552 (is_implicated_in) | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 2.38e-03 | 23 | 93 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 2.38e-03 | 23 | 93 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 2.38e-03 | 23 | 93 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 2.38e-03 | 23 | 93 | 2 | C0014556 | |
| Disease | Allodynia | 2.40e-03 | 84 | 93 | 3 | C0458247 | |
| Disease | Mechanical Allodynia | 2.40e-03 | 84 | 93 | 3 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 2.40e-03 | 84 | 93 | 3 | C0751212 | |
| Disease | Hyperalgesia, Primary | 2.40e-03 | 84 | 93 | 3 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 2.40e-03 | 84 | 93 | 3 | C0751214 | |
| Disease | Tactile Allodynia | 2.40e-03 | 84 | 93 | 3 | C0751213 | |
| Disease | Hyperalgesia | 2.40e-03 | 84 | 93 | 3 | C0020429 | |
| Disease | large artery stroke, coronary artery disease | 2.81e-03 | 25 | 93 | 2 | EFO_0001645, EFO_0005524 | |
| Disease | primary biliary cholangitis (is_marker_for) | 2.81e-03 | 25 | 93 | 2 | DOID:12236 (is_marker_for) | |
| Disease | linoleic acid measurement | 2.88e-03 | 186 | 93 | 4 | EFO_0006807 | |
| Disease | Lymphatic Metastasis | 3.04e-03 | 26 | 93 | 2 | C0024232 | |
| Disease | glycerol measurement | 3.04e-03 | 26 | 93 | 2 | EFO_0010115 | |
| Disease | Depressive Symptoms | 3.04e-03 | 26 | 93 | 2 | C0086132 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AFLFSPLRTWLTLLT | 601 | Q0P6H9 | |
| LDRIFLWLFLIVSVT | 426 | Q05901 | |
| LLLFIICWLPFQIST | 276 | P30411 | |
| FILWLLLGSIIFRSI | 321 | Q96P56 | |
| LFLFALSWLPLSIIN | 236 | P0DMS8 | |
| FSVNLVLFLVTLWIL | 696 | Q9UHX3 | |
| PISLIRFWVLQIIFV | 71 | Q969M2 | |
| VSQLLRVFWLLSLLP | 21 | Q6V0I7 | |
| WPLFIFLILISVRLS | 31 | O95477 | |
| TELLLRWALAPIYFL | 996 | A2A2Z9 | |
| LFFWLVLRRLVTLIT | 111 | Q9UHQ4 | |
| ALTPLRVFTARISWL | 196 | Q96LT6 | |
| LQRFLQILKVLFPSW | 21 | O14678 | |
| GFWRVLLLIFVIALL | 191 | Q86W74 | |
| QTWSVLLLLLLFFIP | 216 | P32239 | |
| KLLLQPSLILFWSFS | 371 | Q8IWG1 | |
| VFIITRLVILPFWIL | 271 | Q96G23 | |
| LLRFWLPFGFILILV | 341 | Q14627 | |
| TIARWEVFLFLAILL | 461 | P04798 | |
| TLVDLQWRLSLLFFV | 51 | Q92806 | |
| LSPLRFWVFQVILVA | 71 | Q8NFK1 | |
| IPLVLLLLLTWNYFL | 826 | Q6DN14 | |
| ILWLTTRQGLPFTIF | 286 | Q6P1M3 | |
| TLPTLCRFLLWAFTI | 6 | Q9GZV7 | |
| FFLLLVAAPRWVLSQ | 6 | P0DP07 | |
| WSLSFLFSIPTLIIF | 171 | Q6W5P4 | |
| WLIIRLPILFAIGVN | 306 | P43220 | |
| FFLLLVAAPRWVLSQ | 6 | A0A075B6R2 | |
| FFLLLVAAPRWVLSQ | 6 | A0A087WSY4 | |
| FFLLLVAAPRWVLSQ | 6 | P0DP06 | |
| FFLLLVAAPRWVLSQ | 6 | A0A0C4DH41 | |
| VRWLQVLLPFLLSLF | 11 | Q9Y5G2 | |
| LVQALRQFLWSFRLP | 141 | Q15438 | |
| KLALLPLLWVLFQRT | 16 | Q6UWB1 | |
| LQIVLSIFFLWRELG | 446 | Q92887 | |
| LLFLLFSLGWVQPSR | 21 | Q13421 | |
| FSGLIILLIFRLIWR | 36 | A8MYU2 | |
| FFLLLVAAPRWVLSQ | 6 | A0A0C4DH34 | |
| ARFPWLLFALILLVF | 21 | Q8NH04 | |
| WARLLRPTVQFFLVA | 191 | O43688 | |
| FFLLLVAAPRWVLSQ | 6 | P01825 | |
| FFLLLVAAPRWVLSQ | 6 | P0DP08 | |
| RLVVLIILTFAAFWL | 221 | Q15722 | |
| SLLVFVLLFTSLWPF | 41 | Q86VF5 | |
| GLNAPTLWLFIFRLR | 51 | P51582 | |
| TLIWLFSLLLSIPFF | 156 | Q99463 | |
| LWYINVTIPRLLAAF | 71 | Q8NGX9 | |
| RAFLIRELFPTWLLV | 76 | P13284 | |
| RTWRLLTFVLALPSV | 26 | Q02221 | |
| FLTATRWLLQELVLF | 961 | Q7Z3S7 | |
| RWVFVCLFLLPLSLI | 31 | Q15392 | |
| RIRLTWLSFTLFVIL | 26 | O43909 | |
| FTRFFILLPWILIVI | 6 | Q9NPZ5 | |
| RLWVLQIIFVSTPSL | 76 | P48165 | |
| VTWILFRYPLTISQL | 231 | P35219 | |
| PLIFIGLRVWSTVRF | 231 | Q5UAW9 | |
| LTFGAAIFLWLITRP | 21 | Q9ULC5 | |
| FITTRLGIFPLWVLN | 271 | Q6ZMG9 | |
| WFIRTLLAVTRPFIS | 251 | Q12982 | |
| TWVVPLLFLFLLSRQ | 6 | P42701 | |
| STALQWLLLLFTRYP | 336 | Q16678 | |
| WLLLLFTRYPDVQTR | 341 | Q16678 | |
| RQVPLWGQLLLFLVF | 221 | P50402 | |
| LFWLLRVVTSLFIGA | 51 | Q1HG43 | |
| LQNIFGVILFLRLTW | 196 | Q9UHW9 | |
| VWSARRLLVLLFTPL | 11 | Q8WWT9 | |
| TPFLVYRLTNIWLEL | 481 | O15244 | |
| FLLFRLAAVWLELPL | 486 | O75751 | |
| WVPLFLLLSRVFSTE | 11 | Q504Y0 | |
| SIVWFLSPILGFLLQ | 71 | Q9UMX9 | |
| RFWPFLVIIVILSAL | 226 | Q9BZW8 | |
| LQNIFGVILFLRLTW | 131 | Q9H2X9 | |
| TPILILDLLVWLRYF | 286 | Q9P1P4 | |
| LWALLNFLLPTIFKS | 891 | P51531 | |
| LIILVVSIFPFWVRL | 26 | P0DP42 | |
| LILRQPSPLWLSFTV | 116 | Q9BSH3 | |
| LWALLNFLLPTIFKS | 921 | P51532 | |
| VWFLLTLLLALFIPD | 376 | Q9NVC3 | |
| LLFQTSIRVLVWLLG | 176 | Q8N6D2 | |
| LYVWTLVAPLVLTNR | 436 | Q9NRX5 | |
| VLVFSLIFWIPFSIL | 676 | P78536 | |
| ARLTVSEWLRLLPFL | 31 | Q8N5K1 | |
| FLVWVTFPLVLILFS | 161 | P35523 | |
| FLLPFWLQVIFISLL | 251 | Q9H8M5 | |
| IPVVILLSWFFLLIR | 166 | Q5T1Q4 | |
| WDLLLLIPNVLFLIF | 46 | Q86W33 | |
| LIPNVLFLIFLLWKL | 51 | Q86W33 | |
| AQRVLLTWLFTLLFL | 6 | Q9H2L4 | |
| FLIFIPVWIFDTILL | 36 | Q9H2L4 | |
| ANYLLWVFTPLILLI | 41 | Q96MH6 | |
| FRWLIPISALQVRLG | 1391 | Q8IVF5 | |
| RPFLLLLWEVTTQSL | 396 | Q86U17 | |
| ALWAPAFLLRSRVVL | 291 | Q9H2V7 | |
| WIIRGPVILSILINF | 296 | P47872 | |
| RLFPLASLVLIYWVS | 6 | Q9NY72 | |
| FLVVTIPLTFVWHRR | 1871 | P08922 | |
| LFIILLVIFLIWRCF | 91 | O14668 | |
| SLWAVLFVLGRLLTL | 251 | Q15629 | |
| VSLISFFLLVRSLWR | 196 | Q9NYW2 | |
| LIINTIQLFTLLLWP | 26 | Q9NRZ5 | |
| EAWRLFLLLAVTLPS | 91 | A0AVI4 | |
| VLLVANILRILFWFG | 56 | Q8N2U9 | |
| FLRIVVWFVSLLALL | 416 | P16473 | |
| RLQWPLLFSRLFEVI | 1401 | Q6PIF6 | |
| NLLLPAGIALRWVTF | 346 | Q9NZM1 |